DIA Offers Clinical Safety and Pharmacovigilance Certification
Wednesday, December 30, 2009
The Drug Information Association (DIA) recently launched its Clinical Safety and Pharmacovigilance Certificate Program—the organization’s third certificate program for clinical research professionals.
The new program focuses on topics related to pre- and postmarketing clinical safety and pharmacovigilance, risk-management strategies, safety inspections, signal detection and data mining, medical approaches in diagnosis and management of adverse drug reactions and drug safety surveillance and epidemiology.
Enrollment in the program is free, and fees for each course vary based on length.